Two doses of Ropivacaine in penile block for circumcision

Comparison of two doses of Ropivacaine in penile block for circumcision: randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308600418875

Enrollment

Registered

2023-08-24

Start date

2023-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Paediatrics Anaesthesia

Interventions

Group Ropi 0.2

Group Ropi 0.4

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: ? age between 1 and 6 years. ? Consent of parents. ? ASA Status or II

Exclusion criteria

Exclusion criteria: ? Contraindication to the drugs used in the study. ? Contraindication to penile blocks. ? Act performed as part of a posthectomy. ? Penile blocks made after circumcision ? Unreachable parents for postoperative assessment ? Postoperative revisions

Design outcomes

Primary

Measure	Time frame
Postoperative pain – FLACC scale	—

Secondary

Measure	Time frame
Intraoperative hemodynamic parameters (heart rate, blood pressure);Postoperative analgesics requirements;Time to first postoperative ambulation;Time to first postoperative urination;Complications	—

Countries

Tunisia

Contacts

Public ContactMehdi Jaidane

Sahloul Teaching Hospital Faculty of medecine of Sousse

mehdi@jaidane.org+21698402987

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026